The role of cytomegalovirus and interleukin-8 in destabilization of atherosclerotic lesions in humans
- Authors: Maltseva S.V.1, Pigarevsky P.V.1, Davydova N.G.1, Snegova V.A.1
-
Affiliations:
- Institute of Experimental Medicine
- Issue: Vol 21, No 1 (2021)
- Pages: 11-17
- Section: Original research
- Published: 10.06.2021
- URL: https://journals.eco-vector.com/MAJ/article/view/58500
- DOI: https://doi.org/10.17816/MAJ58500
- ID: 58500
Cite item
Abstract
Relevance. Currently, the role of persistent infections in the atherogenesis development mechanism is not fully understood. Therefore, it’s important to analyze the role of viral infection against the background of the pro-inflammatory cytokines expression in atherosclerotic plaque destabilization.
The aim of the work was a comparative immunohistochemical study of cytomegalovirus (CMV) and IL-8 in different types of human atherosclerotic lesions during their destabilization.
Materials and methods. The study was carried out on 130 autopsy samples of human aorta. CMV was detected by direct immunofluorescent antibody staining. IL-8 was detected by two-stage streptavidin-biotin antibody staining.
Results. It has been shown that active detection of both CMV and IL-8 is characteristic of atherogenesis foci of the arterial intima with the most intense immune-inflammatory changes. The obtained results indicate the synergism of the cellular response to CMV and IL-8 in the vascular wall during the destabilization atherosclerotic lesions process.
Conclusion. According to the results of the work, it can be concluded that both the presence of CMV in atherosclerotic lesions and the high production of IL-8 play a significant role in the formation of unstable atherosclerotic plaques in the vascular wall.
Keywords
Full Text
About the authors
Svetlana V. Maltseva
Institute of Experimental Medicine
Author for correspondence.
Email: moon25@rambler.ru
SPIN-code: 8367-9096
Scopus Author ID: 6602920398
MD, PhD (Biology), Researcher Associate, Department of General Morphology
Russian Federation, Saint PetersburgPeter V. Pigarevsky
Institute of Experimental Medicine
Email: pigarevsky@mail.ru
ORCID iD: 0000-0002-5906-6771
SPIN-code: 8636-4271
MD, PhD, DSc (Biology), Head of the Department of General Morphology
Russian Federation, Saint PetersburgNatalya G. Davydova
Institute of Experimental Medicine
Email: tatashaspb@yandex.ru
SPIN-code: 4761-3575
MD, PhD (Medicine), Researcher Associate, Department of General Morphology
Russian Federation, Saint PetersburgVlada A. Snegova
Institute of Experimental Medicine
Email: biolaber@inbox.ru
ORCID iD: 0000-0002-9925-2886
SPIN-code: 8088-4446
Researcher Associate, Department of General Morphology
Russian Federation, Saint PetersburgReferences
- Nagornev VA, Maltseva SV. The role of infection in the development of immune inflammation and pathogenesis of atherosclerosis. Pathology Archive. 2000;62(6):55–59. (In Russ.)
- Nagornev VA. Pathogenesis of atherosclerosis. Saint Petersburg: Khromis; 2006. (In Russ.)
- Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 1983;42(8):2476–2479.
- Du Y, Zhang G, Liu Z. Human cytomegalovirus infection and coronary heart disease: a systematic review. Virol J. 2018;15(1):31. doi: 10.1186/s12985-018-0937-3
- Adam E, Melnick JL, DeBakey ME. Cytomegalovirus infection and atherosclerosis. Cent Eur J Public Health. 1997;5(3):99–106.
- Melnick JL, Hu C, Burek J, et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994;42(2):170–174. doi: 10.1002/jmv.1890420213
- Li HZ, Wang Q, Zhang YY, et al. Onset of coronary heart disease is associated with HCMV infection and increased CD14+CD16+ monocytes in a mopulation of weifang, China. Biomed Environ Sci. 2020;33(8):573–582. doi: 10.3967/bes2020.076
- Lebedeva AM, Shpektor AV, Vasilieva EYu, Margolis LB. Cytomegalovirus infection in cardiovascular diseases. Biochemistry (Mosc). 2018;83(12):1437–1447. doi: 10.1134/S0006297918120027
- Niyi-Odumosu FA, Bello OA, Biliaminu SA, et al. Resting serum concentration of high-sensitivity C-reactive protein (hs-CRP) in sportsmen and untrained male adults. Niger J Physiol Sci. 2017;31(2):177–81.
- Pigarevsky PV, Maltseva SV, Snegova VA. Progressive atherosclerotic lesions in humans. Morphological and immuno-inflammatory aspects. Cytokines and inflammation. 2013;12(1–2):5–12. (In Russ.)
- Ragino JuI, Chernjavskij AM, Polonskaja JaV, et al. Contents of proinflammatory cytokines, chemoattractants and destructive metalloproteinases in various tipes of unstable atherosclerotic plaques. The Journal of Atherosclerosis and Dyslipidemias. 2011;(1):23–27. (In Russ.)
- Nagornev VA, Anestiady VH, Zota E. Pathomorphosis of atherosclerosis (immunoaspects). Saint Petersburg; Kishinev; 2008. (In Russ.)
- Pigarevsky PV, Maltseva SV, Snegova VA, et al. The role of Interleukin-8 and T-lymphocytes in atherosclerotic plaque destabilization in human. Medical Academic Journal. 2016;16(2):51–55. (In Russ.)
- Cheng X, Yu X, Ding Y-J, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008;127(1):89–97. doi: 10.1016/j.clim.2008.01.009
- Romuk E, Skrzep-Poloczek B, Wojciechowska C. Selectin-P and interleukin-8 plasma levels in coronary heart disease patients. Eur J Clin Invest. 2002;32(9):657–661. doi: 10.1046/j.1365-2362.2002.01053.x
- Velasquez IM, Frumento P, Johansson K, et al. Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology Program. Int J Cardiol. 2014;172(1):173–178. doi: 10.1016/j.ijcard.2013.12.170
- Popovic M, Smiljanic K, Dobutovic B, et al. Human cytomegalovirus infection and atherothrombosis. Thrombolysis. 2012;(33):160–72.
- Mocarski ES, Stinski M. Persistence of the cytomegalovirus genome in human cells. J Virol. 1979;31(3):761–775. doi: 10.1128/JVI.31.3.761-775.1979
- Lebedeva AM, Albakova RM, Albakova TM. Cytomegalovirus infection and atherosclerosis. Infectious Diseases: News. Opinions. Training. 2017;6(23):72–78. (In Russ.)